Study Group SARS-CoV-2 (+) (n = 30) | Control Group SARS-CoV-2 (-) (n = 60) | P | |
---|---|---|---|
MDI mean ± SDS | 88.51 ± 8.33 | 89.56 ± 12.82 | 0.64 |
PDI mean ± SDS | 89.13 ± 7.49 | 92.30 ± 7.22 | 0.05 |
NDI* Positivity n (%) | 2 (6.6) | 0 | 0.12 |
MDP n (%) | 13 (43.3) | 6 (10) | 0.03 |
Blindness n (%) | 0 | 0 | NS |
Deafness n (%) | 0 | 0 | NS |
CP n (%) | 0 | 0 | NS |
Need for Physical Therapy n (%) | 1 (3.3) | 0 | 0.33 |
Need for Special Education n (%) | 1 (3.3) | 0 | 0.33 |